Effects of an Exergame Focused on Cognitive-motor Interference on the Cognitive and Motor Capacities of Older Adults (INCOME)

July 22, 2022 updated by: University Hospital, Limoges

Ageing is accompanied by a high risk of developing physical or cognitive impairments, as well as a decrease in abilities to perform two tasks simultaneously, contributing to loss of autonomy.

Interventions based on the performance of cognitive-motor dual tasks show positive effects on cognitive, physical and emotional development on dual-tasking capabilities. Exergames, interactive serious games combining physical activity and technology, are a certain type of cognitive-motor dual task training. These exergames appear to be cognitively effective, discussed on a physical level, not studied on dual task functions. It is likely that a dual task cognitive-motor with the support of a exercise leads to the same benefits as training without the need for special support.

In addition, the exergames benefit from specific features such as a good immersion and a playful aspect that increase the participant's adhesion. Moreover, the level of security of this type of programme has been little studied. It is likely that cognitive-motor dual tasks training supported by an exercise programme leads to few undesirable events and good adherence.

Many of the recommendations specific needs gaming state that it is important to develop systems that respond to the needs specific to the population concerned in order to be effective. Within the laboratory HAVAE has been developed a tool, the "virtual carpet":

association between a video-projected scene and a monitoring system of position of the participants. This system makes it possible to use as a grid of play the cartography and iconography of the City of Limoges. The investigators suppose that this emphasis on local heritage will encourage the participants leaving their homes, thereby increasing their level of physical activity and their quality of life.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Limoges, France, 87000
        • Résidence Autonomie CASSEAUX
      • Limoges, France, 87000
        • Résidence Autonomie DURKHEIM

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

73 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

A person over 75 years of age who :

  • resides in one of the two Municipal Autonomy Residences (RAM) of the City of Limoges (Durkheim or Casseaux), or a member of a senior club of the communal social action centre
  • has normal or corrected vision and hearing

Exclusion Criteria:

Person presenting :

  • psychiatric disorders or neurological pathologies (cardiovascular accidents, Parkinson's disease, Alzheimer's, dementia) diagnosed
  • taking medication that affects walking or balance
  • a need for technical assistance (double cane-crutch, walker)
  • an inability to carry out the proposed training programme
  • person unable to understand the Protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Arm
Training programme using Exergame as a support over a 12 week period
Cognitive-motor dual task exercises corresponding to associations between different motor tasks and different cognitive tasks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postural control under dual-task condition change
Time Frame: Week 3, Week 17
assessed by posturography (mm/s)
Week 3, Week 17

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mental inhibition under dual-task condition change
Time Frame: Week 3, Week 17, Week 31
assessed by Stroop test time (s)
Week 3, Week 17, Week 31
Mental inhibition under dual-task condition change
Time Frame: Week 3, Week 17, Week 31
assessed by Stroop test errors (n)
Week 3, Week 17, Week 31
Mental inhibition change single-task condition
Time Frame: Week 3, Week 17, Week 31
assessed by Stroop test time (s)
Week 3, Week 17, Week 31
Mental inhibition change single-task condition
Time Frame: Week 3, Week 17, Week 31
assessed by Stroop test errors (n)
Week 3, Week 17, Week 31
Mental flexibility change
Time Frame: Week 3, Week 17, Week 31
assessed by TMT time (s)
Week 3, Week 17, Week 31
Mental flexibility change
Time Frame: Week 3, Week 17, Week 31
assessed by Stroop test errors (n)
Week 3, Week 17, Week 31
Working memory change
Time Frame: Week 3, Week 17, Week 31
assessed by 2N-Back test errors (n)
Week 3, Week 17, Week 31
Mobility change
Time Frame: Week 3, Week 17, Week 31
assessed by TUG time (s)
Week 3, Week 17, Week 31
Balance change
Time Frame: Week 3, Week 17, Week 31
assessed by BBS score
Week 3, Week 17, Week 31
Fear of falling
Time Frame: Week 3, Week 17, Week 31
assessed by FES-I score
Week 3, Week 17, Week 31
Postural control under single-task condition change
Time Frame: Week 3, Week 17, Week 31
assessed by posturography (mm/s)
Week 3, Week 17, Week 31
Reported physical activity level change
Time Frame: Week 3, Week 17, Week 31
assessed by QAPPA score
Week 3, Week 17, Week 31
Traqued physical activity level change
Time Frame: Week 3, Week 17, Week 31
assessed by embeded Armband
Week 3, Week 17, Week 31
City exploration change
Time Frame: Week 17, Week 31
assessed by the city's points of interest visits
Week 17, Week 31
Quality of life change
Time Frame: Week 3, Week 17, Week 31
assessed by EQ5D5L score
Week 3, Week 17, Week 31
Safety features of the training programme
Time Frame: Week 17
number, nature, severity and causes of the occurrence of adverse events during the intervention
Week 17
Compliance
Time Frame: Week 17
assessed by number of sessions carried out
Week 17
Drop-out
Time Frame: Week 17
assessed by the number of participants who do not complete the program
Week 17
Motivation change
Time Frame: Week 3, Week 17, Week 31
assessed by EMAPS score
Week 3, Week 17, Week 31

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 14, 2021

Primary Completion (Actual)

March 31, 2022

Study Completion (Actual)

March 31, 2022

Study Registration Dates

First Submitted

March 8, 2021

First Submitted That Met QC Criteria

March 16, 2021

First Posted (Actual)

March 18, 2021

Study Record Updates

Last Update Posted (Actual)

July 25, 2022

Last Update Submitted That Met QC Criteria

July 22, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 87RI20_0047 (INCOME)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ageing

Clinical Trials on Training Programme

3
Subscribe